Literature DB >> 9010015

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

J Kulisevsky1, A Avila, M Barbanoj, R Antonijoan, M L Berthier, A Gironell.   

Abstract

The contribution of dopaminergic systems to cognitive defects in Parkinson's disease and the cognitive effects of levodopa remain controversial. The levodopa plasma levels and the neuropsychological performance of 10 parkinsonian patients with a stable motor response to the drug and 10 matched parkinsonian patients with a 'wearing-off' phenomenon were studied 12 h after levodopa was withdrawn (time zero), and at 1 h and 4 h after an oral dose of levodopa (i.e. at '+1H' and '+4H'), to investigate whether discrete cognitive domains are more sensitive to levodopa in parkinsonian patients with the wearing-off phenomenon. Considering the 20 patients as a whole, levodopa significantly diminished the response time in verbal and visuospatial memory tests, the extradimensional matching test and the Wisconsin card sorting test (WCST), without significantly improving or worsening the patient's accuracy. A significant group-by-time effect was only evident in the WCST; while in stable patients levodopa produced no changes, wearing-off patients significantly reduced the number of categories achieved and had more perseverative errors at +1H, recovering at +4H. These results confirm previous findings of selective adverse effects of levodopa on highly demanding executive tasks in Parkinson's disease and additionally suggest that some previous discrepancies between studies may be accounted for by lack of differentiation between stable and wearing-off conditions. 'Frontal' disturbances on neuropsychological tests with levodopa may become evident only after massive degeneration of the dopamine systems has occurred.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9010015     DOI: 10.1093/brain/119.6.2121

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  29 in total

1.  Striatal dopamine influences the default mode network to affect shifting between object features.

Authors:  Linh C Dang; Aneesh Donde; Cindee Madison; James P O'Neil; William J Jagust
Journal:  J Cogn Neurosci       Date:  2012-05-29       Impact factor: 3.225

Review 2.  Mild cognitive impairment in Parkinson's disease.

Authors:  Saul Martinez-Horta; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2019-04-08       Impact factor: 3.575

Review 3.  Rule-based category learning in patients with Parkinson's disease.

Authors:  Amanda Price; J Vincent Filoteo; W Todd Maddox
Journal:  Neuropsychologia       Date:  2009-02-02       Impact factor: 3.139

4.  Prospective memory in Parkinson disease across laboratory and self-reported everyday performance.

Authors:  Erin R Foster; Mark A McDaniel; Grega Repovs; Tamara Hershey
Journal:  Neuropsychology       Date:  2009-05       Impact factor: 3.295

5.  Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study.

Authors:  Ji Hyun Ko; Alain Ptito; Oury Monchi; Sang Soo Cho; Thilo Van Eimeren; Giovanna Pellecchia; Benedicte Ballanger; Pablo Rusjan; Sylvain Houle; Antonio P Strafella
Journal:  Neuroimage       Date:  2009-03-03       Impact factor: 6.556

Review 6.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

7.  The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson's disease.

Authors:  H Srovnalova; R Marecek; R Kubikova; I Rektorova
Journal:  Exp Brain Res       Date:  2012-09-14       Impact factor: 1.972

Review 8.  The many facets of motor learning and their relevance for Parkinson's disease.

Authors:  Lucio Marinelli; Angelo Quartarone; Mark Hallett; Giuseppe Frazzitta; Maria Felice Ghilardi
Journal:  Clin Neurophysiol       Date:  2017-04-09       Impact factor: 3.708

Review 9.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

10.  Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.

Authors:  Kolbjorn Bronnick; Murat Emre; Roger Lane; Sibel Tekin; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.